Thiazolidinedione treatment and constitutive-PPARγ activation induces ectopic adipogenesis and promotes age-related thymic involution

Aging Cell

Volumn 9, Issue 4, 2010, Pages 478-489

  Youm, Yun Hee ^a   Yang, Hyunwon ^a   Amin, Raj ^a   Smith, Steven R ^a   Leff, Todd ^b   Dixit, Vishwa D ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Bone marrow adipocytes; Insulin; Kgf; Mesenchymal; T cells

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CALVASCULIN; HYBRID PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; T LYMPHOCYTE RECEPTOR; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; GENETIC MANIPULATION; GLUCOSE HOMEOSTASIS; HEMATOPOIETIC STEM CELL; MALE; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA CELL; T LYMPHOCYTE; THYMUS; TRANSGENE; AGING; ANIMAL; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; OBESITY; PATHOLOGY; TRANSGENIC MOUSE;

ADIPOGENESIS; ADIPOSITY; AGING; ANIMALS; BONE MARROW; IMMUNOLOGIC MEMORY; LIGANDS; MICE; MICE, TRANSGENIC; PPAR GAMMA; RECEPTORS, ANTIGEN, T-CELL; THIAZOLIDINEDIONES; THYMUS GLAND;

EID: 77955652947     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2010.00574.x     Document Type: Article

References (60)

1. Anderson G, Jenkinson EJ (2001) Lymphostromal interactions in thymic development and function. Nat. Rev. Immunol. 1, 31-40.
2. Aspinall R, Mitchell W (2008) Reversal of age-associated thymic atrophy: treatments, delivery, and side effects. Exp. Gerontol. 43, 700-705.
3. Bhandoola A, von Boehmer H, Petrie HT, Zúñiga-Pflücker JC (2007) Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity 26, 678-689.
4. von Boehmer H, Aifantis I, Azogui O, Feinberg J, Saint-Ruf C, Zober C, Garcia C, Buer J (1998) Crucial function of the pre-T-cell receptor (TCR) in TCR beta selection, TCR beta allelic exclusion and alpha beta versus gamma delta lineage commitment. Immunol. Rev. 165, 111-119.
5. Camp HS, Tafuri SR (1997) Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J. Biol. Chem. 272, 10811-10816.
6. Camp HS, Tafuri SR, Left T (1999) c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity. Endocrinology 140, 392-397.
7. Chidgey A, Dudakov J, Seach N, Boyd R (2007) Impact of niche aging on thymic regeneration and immune reconstitution. Semin. Immunol. 19, 331-340.
8. Dixit VD (2008) Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. J. Leukoc. Biol. 84, 882-892.
9. Dixit VD, Yang H, Sun Y, Weeraratna AT, Youm YH, Smith RG, Taub DD (2007) Ghrelin promotes thymopoiesis during aging. J. Clin. Invest. 117, 2778-2790.
10. Dowell P, Ishmael JE, Avram D, Peterson VJ, Nevrivy DJ, Leid M (1997) p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 272, 33435-33443.
11. Evans R, Barish GD, Wang YX (2004) PPARs and the complex journey to obesity. Nat. Med. 10, 1-7.
12. Flores KG, Li J, Sempowski GD, Haynes BF, Hale LP (1999) Analysis of the human thymic perivascular space during aging. J. Clin. Invest. 104, 1031-1039.
13. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB (2003) Years of life lost due to obesity. JAMA 8, 187-193.
14. Foster K, Sheridan J, Veiga-Fernandes H, Roderick K, Pachnis V, Adams R, Blackburn C, Kioussis D, Coles M (2008) Contribution of neural crest-derived cells in the embryonic and adult thymus. J. Immunol. 180, 3183-3189.
15. Furuhashi M, Tuncman G, Gö rgü n CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447, 959-965.
16. Gesta S, Tseng YH, Kahn CR (2007) Developmental origin of fat: tracking obesity to its source. Cell 131, 242-256.
17. Goodman RH, Smolik S (2000) CBP/p300 in cell growth, transformation, and development. Genes Dev. 14, 1553-1577.
18. Gorochov G, Neumann AU, Kereveur A, Parizot C, Li T, Katlama C, Karmochkine M, Raguin G, Autran B, Debré P (1998) Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat. Med. 4, 215-221.
19. Gray DH, Seach N, Ueno T, Milton MK, Liston A, Lew AM, Goodnow CC, Boyd RL (2006) Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells. Blood 108, 3777-3785.
20. Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DE, Magnuson MA, Redha R, Zhang Y, Breyer MD (2005) Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat. Med. 11, 861-866.
21. Hale JS, Boursalian TE, Turk GL, Fink PJ (2006) Thymic output in aged mice. Proc. Natl Acad. Sci. USA 103, 8447-8452.
22. Lago RM, Singh PP, Nesto RW (2007) Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet 370, 1129-1136.
23. Landreth G, Jiang Q, Mandrekar S, Heneka M (2008) PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease. Neurotherapeutics 5, 481-489.
24. Linton PJ, Dorshkind K (2004) Age-related changes in lymphocyte development and function. Nat. Immunol. 5, 133-139.
25. Lu FP, Lin KP, Kuo HK (2009) Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS ONE 4, e4144.
26. Lynch HE, Goldberg GL, Chidgey A, Van den Brink MR, Boyd R, Sempowski GD (2009) Thymic involution and immune reconstitution. Trends Immunol. 30, 366-373.
27. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 16, 704-715.
28. Masternak MM, Bartke A (2007) PPARs in calorie restricted and genetically long-lived mice. PPAR Res. 2007, 1-7.
29. McDonough AK, Rosenthal RS, Cao X, Saag KG (2008) The effect of thiazolidinediones on BMD and osteoporosis. Nat. Clin. Pract. Endocrinol. Metab. 4, 507-513.
30. Miller RA (1996) The aging immune system: primer and prospectus. Science 273, 70-74.
31. Morley JE (2008) Diabetes and aging: epidemiologic overview. Clin. Geriatr. Med. 24, 395-405.
32. Müller SM, Stolt CC, Terszowski G, Blum C, Amagai T, Kessaris N, Iannarelli P, Richardson WD, Wegner M, Rodewald HR (2008) Neural crest origin of perivascular mesenchyme in the adult thymus. J. Immunol. 180, 5344-5351.
33. Napolitano LA, Schmidt D, Gotway MB, Ameli N, Filbert EL, Ng MM, Clor JL, Epling L, Sinclair E, Baum PD, Li K, Killian ML, Bacchetti P, McCune JM (2008) Growth hormone enhances thymic function in HIV-1-infected adults. J. Clin. Invest. 118, 1085-1098.
34. Nasi M, Troiano L, Lugli E, Pinti M, Ferraresi R, Monterastelli E, Mussi C, Salvioli G, Franceschi C, Cossarizza A (2006) Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: implications for the neolymphogenesis at the limit of human life. Aging Cell 5, 167-175.
35. National Institute on Aging, National Institutes of Health. Publication No. 07-6134, March 2007.
36. Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ (2009) Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 460, 259-263.
37. Naylor K, Li G, Vallejo AN, Lee WW, Koetz K, Bryl E, Witkowski J, Fulbright J, Weyand CM, Goronzy JJ (2005) The influence of age on T cell generation and TCR diversity. J. Immunol. 174, 7446-7452.
38. Nikolich-Zugich J, Slifka MK, Messaoudi I (2004) The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 4, 123-132.
39. Pannetier C, Cochet M, Darche S, Casrouge A, Zöller M, Kourilsky P (1993) The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl Acad. Sci. USA 90, 4319-4323.
40. Poulsen P, Grunnet LG, Pilgaard K, Storgaard H, Alibegovic A, Sonne MP, Carstensen B, Beck-Nielsen H, Vaag A (2009) Increased risk of type 2 diabetes in elderly twins. Diabetes 58, 1350-1355.
41. Purushotham A, Wendel AA, Liu LF, Belury MA (2007) Maintenance of adiponectin attenuates insulin resistance induced by dietary conjugated linoleic acid in mice. J. Lipid Res. 48, 444-452.
42. Rubenstrunk A, Hanf R, Hum DW, Fruchart JC, Staels B (2007) Safety issues and prospects for future generations of PPAR modulators. Biochim. Biophys. Acta 1771, 1065-1081.
43. Saltiel AR, Olefsky JM (1996) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45, 1661-1669.
44. Sauce D, Larsen M, Fastenackels S, Duperrier A, Keller M, Grubeck-Loebenstein B, Ferrand C, Debré P, Sidi D, Appay V (2009) Evidence of premature immune aging in patients thymectomized during early childhood. J. Clin. Invest. 119, 3070-3078.
45. Sempowski GD, Gooding ME, Liao HX, Le PT, Haynes BF (2002) T cell receptor excision circle assessment of thymopoiesis in aging mice. Mol. Immunol. 8, 841-848.
46. Sierra F, Hadley E, Suzman R, Hodes R (2009) Prospects for life span extension. Annu. Rev. Med. 60, 457-469.
47. Sporn MB, Suh N, Mangelsdorf DJ (2001) Prospects for prevention and treatment of cancer with selective PPARgamma modulators (SPARMs). Trends Mol. Med. 7, 395-400.
48. Staels B, Fruchart JC (2005) Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 54, 2460-2470.
49. Swain S, Clise-Dwyer K, Haynes L (2005) Homeostasis and the age-associated defect of CD4 T cells. Semin. Immunol. 17, 370-377.
50. Taub DD, Longo DL (2005) Insights into thymic aging and regeneration. Immunol. Rev. 205, 72-93.
51. Tontonoz P, Spiegelman BM (2008) Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 77, 289-312.
52. Wan Y, Chong LW, Evans RM (2007) PPAR-gamma regulates osteoclastogenesis in mice. Nat. Med. 13, 1496-1503.
53. Wang YC, Colditz GA, Kuntz KM (2007) Forecasting the obesity epidemic in the aging U.S. population. Obesity 15, 2855-2865.
54. Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA (2008) Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J. Exp. Med. 205, 711-723.
55. Yang H, Youm YH, Vandanmagsar B, Rood J, Kumar KG, Butler AA, Dixit VD (2009a) Obesity accelerates thymic aging. Blood 114, 3803-3812.
56. Yang H, Youm YH, Rim JS, Galbán CJ, Vandanmagsar B, Dixit VD (2009b) Axin expression in thymic stromal cells contributes to agerelated increase in thymic adiposity and associated with reduced thymopoiesis independently of ghrelin signaling. J. Leukoc. Biol. 85, 928-938.
57. Yang H, Youm YH, Dixit VD (2009c) Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution. J. Immunol. 183, 3040-3052.
58. Yki-Järvinen H (2004) Thiazolidinediones. N. Engl. J. Med. 351, 1106-1118.
59. Youm YH, Yang H, Sun Y, Smith RG, Manley NR, Dixit VD (2009) Deficient Ghrelin receptor mediated signaling compromises thymic stromal cell microenvironment by accelerating thymic adiposity. J. Biol. Chem. 284, 7068-7077.
60. Zeisberg M, Neilson EG (2009) Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 119, 1429-1437.